Erythropoietic stimulating factor (ESF) in blood from humans with cancer and animals with Novikoff hepatomas

Leaders, Floyd E.

doi:10.1002/1097-0142(196504)18:4<496::aid-cncr2820180413>3.0.co;2-i

Cancer

1965

DOI: 10.1002/1097-0142(196504)18:4<496::aid-cncr2820180413>3.0.co;2-i

|View full text |Cite

Erythropoietic stimulating factor (ESF) in blood from humans with cancer and animals with Novikoff hepatomas

Floyd E. Leaders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2010

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Erythropoietin and the truths of science

Buemi¹,

Campo²,

Cernaro³

et al. 2010

View full text Add to dashboard Cite

In recent years, the use of recombinant human erythropoietin (rHuEpo) has exploded all over the world, and thanks to this, the anemia of patients with chronic renal failure has practically been resolved with its administration. Administration of rHuEpo certainly plays a role in regenerative medicine in vitro and in vivo, because it intervenes in angiogenesis, the persistent natural regenerative activity of humans. Unfortunately, in recent randomized studies, the beneficial effects of rHuEpo have been accompanied by an unanticipated increase in mortality. Its effects are negative in presence of cancer development, but positive in other conditions, as it can protect heart tissue, brain and kidney. Now that its adverse effects have caused the US Food and Drug Administration to issue a black-box warning, it may be time to review what we know about the history and physiology of this plasma factor that appears to be more than just an erythrocyte production factor. Directions for future research hold promise, but only after we have fully understood the physiology of this potent growth factor.

show abstract

Erythropoietin and the truths of science

Buemi¹,

Campo²,

Cernaro³

et al. 2010

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Erythropoietic stimulating factor (ESF) in blood from humans with cancer and animals with Novikoff hepatomas

Cited by 1 publication

References 9 publications

Erythropoietin and the truths of science

Erythropoietin and the truths of science

Contact Info

Product

Resources

About